title: Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis.
abstract: The acidic ribosomal proteins of the protozoan parasites have been described as prominent antigens during human disease. We present here data showing the molecular cloning and protective efficacy of P1 gene of Leishmania donovani as DNA vaccine. The PCR amplified complete ORF cloned in either pQE or pVAX vector was used either as peptide or DNA vaccine against experimentally induced visceral leishmaniasis in hamsters. The recombinant protein rLdP1 was given along with Freund's adjuvant and the plasmid DNA vaccine, pVAX-P1 was used alone either as single dose or double dose (prime and boost) in different groups of hamsters which were subsequently challenged with a virulent dose of 1×10(7) L. donovani (MHOM/IN/DD8/1968 strain) promastigotes by intra-cardiac route. While the recombinant protein rLdP1 or DNA vaccine pVAX-P1 in single dose format were not found to be protective, DNA vaccine in a prime-boost mode was able to induce protection with reduced mortality, a significant (75.68%) decrease in splenic parasite burden and increased expression of Th1 type cytokines in immunized hamsters. Histopathology of livers and spleens from these animals showed formation of mature granulomas with compact arrangement of lymphocytes and histiocytes, indicating its protective potential as vaccine candidate.
authors.affiliation: Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
authors.forename: Shet
authors.initials: S
authors.lastname: Masih
authors.forename: Sunil K
authors.initials: SK
authors.lastname: Arora
authors.forename: Rakesh K
authors.initials: RK
authors.lastname: Vasishta
mesh_terms: D000818:Animals; D000953:Antigens, Protozoan / Q000235:genetics* / Q000276:immunology; D003001:Cloning, Molecular; D006224:Cricetinae; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics; D015870:Gene Expression; D007893:Leishmania donovani / Q000235:genetics* / Q000276:immunology*; D007898:Leishmaniasis, Visceral / Q000517:prevention & control*; D008099:Liver / Q000469:parasitology / Q000473:pathology; D008214:Lymphocytes / Q000276:immunology / Q000473:pathology; D008647:Mesocricetus; D010750:Phosphoproteins / Q000235:genetics / Q000276:immunology; D016052:Protozoan Vaccines / Q000235:genetics / Q000592:standards; D011897:Random Allocation; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D012269:Ribosomal Proteins / Q000235:genetics / Q000276:immunology; D013154:Spleen / Q000276:immunology / Q000469:parasitology / Q000473:pathology; D019444:Vaccines, DNA / Q000235:genetics / Q000592:standards
chemical_list: D000953:Antigens, Protozoan; D016207:Cytokines; D010750:Phosphoproteins; D016052:Protozoan Vaccines; D011994:Recombinant Proteins; D012269:Ribosomal Proteins; D019444:Vaccines, DNA; C035690:ribosomal phosphoprotein P1